Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05198297 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the Hydrus Microstent
A NA study, sponsored by Alcon Research.
- Terminated
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT05198297 is a NA study that was terminated before completion, run by Alcon Research. The registered enrollment target is 33 participants.
The verdict
NCT05198297, a NA study, was terminated before completion, sponsored by Alcon Research.
- TERMINATED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and effectiveness of the Hydrus Microstent for lowering intraocular pressure (IOP) in pseudophakic patients with open-angle glaucoma for whom IOP is not sufficiently controlled on topical hypotensive medication and prior to incisional glaucoma surgery.
Interventions
- DEVICE Hydrus Microstent
- PROCEDURE Ophthalmic surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2021-12-13 |
| Est. Completion | 2024-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05198297
The ClinicalTrials.gov registry entry for NCT05198297 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydrus Microstent is the first listed.
NCT05198297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05198297 about?
NCT05198297 is a clinical study titled "Safety and Effectiveness of the Hydrus Microstent". The purpose of this study is to assess the safety and effectiveness of the Hydrus Microstent for lowering intraocular pressure (IOP) in pseudophakic patients with open-angle glaucoma for whom IOP is not sufficiently controlled on topical hypotensive medication and prior to incisional glaucoma surger...
What is the current status of trial NCT05198297?
This trial is currently terminated. It is a NA study. The enrollment target is 33 participants. The study started on 2021-12-13. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT05198297?
The interventions under investigation include: Hydrus Microstent (DEVICE), Ophthalmic surgery (PROCEDURE).
Who is sponsoring clinical trial NCT05198297?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.